A cohort study on the pathogenesis and physical basis of idiopathic membranous nephropathy

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ITMCTR

Registry ID

ITMCTR2000003385

Enrollment

Unknown

Registered

2020-06-08

Start date

2020-06-15

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic membranous nephropathy

Interventions

Low risk group vs medium risk group vs high risk group:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-85 years; 2. Patients with renal biopsy consistent with IMN diagnosis; 3. Serum PLA2R antibody was positive and no secondary factors were found.

Exclusion criteria

Exclusion criteria: 1. Patients with glomerular filtration rate less than 15 ml / min; 2. Patients with active malignant tumor; 3. Patients with severe primary diseases such as decompensated cirrhosis or hemopoietic system; 4. Psychopaths.

Design outcomes

Primary

Measure	Time frame
composite remission rate (complete or partial remission);	—

Secondary

Measure	Time frame
Total serum protein;Partial remission rate;Serum albumin;PLA2R antibody;uric acid;Serum creatinine;Glomerular filtration rate;White blood cell;Complete remission rate;blood platelet;serum potassium;blood glucose;triglyceride;Urine protein creatinine ratio;cholesterol;hemoglobin;Red blood cell;24-hour urinary protein;LDL;	—

Countries

China

Contacts

Public ContactBao Kun

Guangdong Provincial Hospital of Chinese Medicine

baokun@aliyun.com+86 13711224369

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026